Desmoid tumor, desmoplastic fibroma, periosteal desmoid tumor, osteofibrous dysplasia and fibrous dysplasia are benign mesenchymal lesions arising in soft tissue or bone. Desmoid tumors, also known as aggressive fibromatosis or fibromatosis of soft tissue, may occur in extraabdominal, abdominal, or intra-abdominal locations. Desmoplastic fibroma and periosteal desmoid tumor, identical histologically, differ only by location. Desmoplastic fibroma and periosteal desmoid tumor are considered to represent the bone counterparts of desmoid tumors of soft tissue. A tumor-like proliferation of fibroosseous tissue is characteristic of osteofibrous dysplasia and fibrous dysplasia. The former is distinguished histologically by osteoblastic rimming of the bone trabeculae. Cytogenetic and molecular cytogenetic analyses of desmoid tumors are few and are particularly sparse or are nonexistent for desmoplastic fibroma, periosteal desmoid tumor, osteofibrous dysplasia, and fibrous dysplasia. [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] To determine the frequency of trisomy 8 and trisomy 20 in additional desmoid tumor cases and to examine their presence in related fibrous lesions of bone, both standard karyotypic analysis and molecular cytogenetic analysis were performed on 22 representative specimens.
Materials and Methods
Cytogenetic AnalysisTwenty-two specimens (to include three desmoplastic fibromas, two periosteal desmoid tumors, nine desmoid tumors, four osteofibrous dysplasias, and four fibrous dysplasias) from 19 different patients were examined by traditional cytogenetic and molecular cytogenetic methodologies. A 0.5-to 1.0-cm 3 sample of each specimen was received for cytogenetic analysis. Standard culture and harvesting procedures were used that have been described previously. 4 Briefly, the tissues were disaggregated mechanically and enzymatically and then cultured in RPMI 1640 medium supplemented with 20% fetal bovine serum and 1% penicillin/streptomycin-L-glutamine (Irvine Scientific, Santa Ana, CA) for 3 to 5 days. Two to four hours before harvest, cells were exposed to Colcemid (0.02 g/ml). After hypotonic treatment (0.074 mol/L KCl for 30 minutes for flasks and 0.8% sodium citrate for 25 minutes for coverslips), the preparations were fixed three times with methanol/glacial acetic acid (3:1). Metaphase cells were banded with Giemsa trypsin. The karyotypes were expressed according to the International System for Human Cytogenetic Nomenclature 1995. 18